Targeted Drug Shrinks Tumors In Hard-To-Treat Cancer
RSS SUMMARY · AGGREGATED FROM FORBES
A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent chemotherapy directly into cancer cells.
A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent chemotherapy directly into cancer cells.
A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent chemotherapy directly into cancer cells.
Continue Reading
The full story continues on Forbes.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
FORBES
Tech
NYT Strands Answers Today: Hints & Clues For Thursday, June 4 (Smooth Moves)
FORBES·1h ago·3 min read
Tech
AI Agents Put Creative Control Back On The Table
FORBES·1h ago·3 min read
Tech
NYT ‘Pips’ Hints, Answers And Walkthrough For Thursday, June4
FORBES·1h ago·3 min read
Tech
Today’s Wordle #1811 Hints And Answer For Thursday, June 4
FORBES·50m ago·3 min read
Related
On this beat
Tech
Quote of the day by Anthropic CEO Dario Amodei: “Humanity is about to be handed almost unimaginable power, and it is deeply unclear whether [we] possess the maturity to wield it” — warnings on the looming threat of beyond-human AI
TECHRADAR·1h ago·3 min read
Tech
Dyson HushJet Mini Cool vs Shark ChillPill: in the battle of the portable fans, there’s a clear winner
TECHRADAR·1h ago·3 min read
Tech
Quordle hints and answers for Thursday, June 4 (game #1592)
TECHRADAR·43m ago·3 min read
Tech
Huawei’s chairman officially thanks the US government ‘for enabling’ China’s ‘semiconductor industry chain to truly grow’
TECHRADAR·48m ago·3 min read